Goldhaber J I, Weiss J N
Division of Cardiology, UCLA School of Medicine 90024.
Hypertension. 1992 Jul;20(1):118-27. doi: 10.1161/01.hyp.20.1.118.
Oxygen free radicals are highly reactive compounds causing peroxidation of lipids and proteins and are thought to play an important role in the pathogenesis of reperfusion abnormalities including myocardial stunning, irreversible injury, and reperfusion arrhythmias. Free radical accumulation has been measured in ischemic and reperfused myocardium directly using techniques such as electron paramagnetic resonance spectroscopy and tissue chemiluminescence and indirectly using biochemical assays of lipid peroxidation products. Potential sources of free radicals during ischemia and reperfusion have been identified in myocytes, vascular endothelium, and leukocytes. In several different experimental models exogenous free radical-generating systems have been shown to produce alterations in cardiac function that resemble the various reperfusion abnormalities described above. Injury to processes involved in regulation of the intracellular Ca2+ concentration may be a common mechanism underlying both free radical-induced and reperfusion abnormalities. Direct effects of free radicals on each of the known Ca(2+)-regulating mechanisms of the cell as well as the contractile proteins and various ionic membrane currents have been described. Free radicals also inhibit critical enzymes in anaerobic and aerobic metabolic pathways, which may limit the metabolic reserve of reperfused myocardium and contribute to intracellular Ca2+ overload. Inhibiting free radical accumulation during myocardial ischemia/reperfusion with free radical scavengers and inhibitors has been demonstrated to reduce the severity of myocardial stunning, irreversible injury, and reperfusion arrhythmias in many, but not all, studies. This evidence strongly implicates free radical accumulation during myocardial ischemia/reperfusion as an important pathophysiological mechanism of reperfusion abnormalities, although many issues remain unresolved.
氧自由基是高反应性化合物,可导致脂质和蛋白质过氧化,被认为在包括心肌顿抑、不可逆损伤和再灌注心律失常在内的再灌注异常的发病机制中起重要作用。已使用电子顺磁共振光谱和组织化学发光等技术直接测量缺血和再灌注心肌中的自由基积累,并通过脂质过氧化产物的生化测定间接测量。已在心肌细胞、血管内皮细胞和白细胞中确定了缺血和再灌注期间自由基的潜在来源。在几种不同的实验模型中,外源性自由基生成系统已被证明会导致心脏功能改变,类似于上述各种再灌注异常。对细胞内Ca2+浓度调节过程的损伤可能是自由基诱导的异常和再灌注异常共同的潜在机制。已经描述了自由基对细胞已知的每种Ca(2+)调节机制以及收缩蛋白和各种离子膜电流的直接影响。自由基还抑制无氧和有氧代谢途径中的关键酶,这可能会限制再灌注心肌的代谢储备并导致细胞内Ca2+过载。在许多但并非所有研究中,已证明用自由基清除剂和抑制剂抑制心肌缺血/再灌注期间的自由基积累可降低心肌顿抑、不可逆损伤和再灌注心律失常的严重程度。这一证据强烈表明,心肌缺血/再灌注期间的自由基积累是再灌注异常的重要病理生理机制,尽管许多问题仍未解决。